SUIT, secretory units of islets in transplantation: An index for therapeutic management of islet transplanted patients and its application to type 2 diabetes

Diabetes Research and Clinical Practice

Volumn 74, Issue 3, 2006, Pages 222-226

  Yamada, Yuichiro ^a   Fukuda, Kazuhito ^a   Fujimoto, Shimpei ^a   Hosokawa, Masaya ^a   Tsukiyama, Katsushi ^a   Nagashima, Kazuaki ^a   Fukushima, Mitsuo ^a   Suzuki, Haruhiko ^a   Toyoda, Kentaro ^a   Sassa, Mariko ^a   Funakoshi, Shogo ^a   Inagaki, Nobuya ^a   Taniguchi, Ataru ^b   Sato, T Shun ^c   Matsumoto, Shinichi ^a   Tanaka, Koichi ^a   Seino, Yutaka ^a,b  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KANSAI ELECTRIC POWER CO   (Japan)

^c KYOTO UNIVERSITY SCHOOL OF PUBLIC HEALTH   (Japan)

Author keywords

Diabetes; Insulin; Islet transplantation

Indexed keywords

C PEPTIDE; GLUCOSE; INSULIN;

ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD SAMPLING; CELL FUNCTION; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PREDICTION; SECRETORY CELL; SECRETORY UNITS OF ISLETS IN TRANSPLANTATION;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION;

EID: 33750020296     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2006.03.030     Document Type: Article

References (20)

1. DeFronzo R.A., Tobin J.D., and Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am. J. Physiol. 237 (1979) E214-E223
2. Bergman R.N., Phillips L.S., and Cobelli C. Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and β-cell glucose sensitivity from the response to intravenous glucose. J. Clin. Invest. 68 (1981) 1456-1467
3. Jones C.N., Pei D., Staris P., Polonsky K.S., Chen Y.D., and Reaven G.M. Alterations in the glucose-stimulated insulin secretory dose-response curve and in insulin clearance in nondiabetic insulin-resistant individuals. J. Clin. Endocrinol. Metab. 82 (1997) 1834-1838
4. Butler A.E., Janson J., Bonner-Weir S., Ritzel R., Rizza R.A., and Butler P.C. β-cell deficit and increased β-cell apoptosis in humans with type 2 diabetes. Diabetes 52 (2003) 102-110
5. Shapiro A.M., Lakey J.R., Ryan E.A., Korbutt G.S., Toth E., Warnock G.L., et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N. Engl. J. Med. 343 (2000) 230-238
6. Shapiro A.M., Ricordi C., and Hering B. Edmonton's islet success has indeed been replicated elsewhere. Lancet 362 (2003) 1242
7. Ricordi C. Islet transplantation: a brave new world. Diabetes 52 (2003) 1595-1603
8. 2) method of pancreas preservation on human islet isolation, as assessed by the Edmonton Isolation Protocol. Transplantation 74 (2002) 1414-1419
9. S. Matsumoto, T. Okitsu, Y. Iwanaga, H. Noguchi, H. Nagata, Y. Yonekawa, et al., Successful islet transplantation from non-heart-beating donor pancreata using modified Ricordi islet isolation method, Transplantation, in press.
10. Matsumoto S., Okitsu T., Iwanaga Y., Noguchi H., Nagata H., Yonekawa Y., et al. Insulin independence after living-donor distal pancreatectomy and islet allotransplantation. Lancet 365 (2005) 1642-1644
11. Samols E., Tyler J., Marri G., and Marks V. Stimulation of glucagon secretion by oral glucose. Lancet 2 (1965) 1257-1259
12. Ryan E.A., Lakey J.R., Paty B.W., Imes S., Korbutt G.S., Kneteman N.M., et al. Successful islet transplantation: continued insulin reserve provides long-term glycemic control. Diabetes 51 (2002) 2148-2157
13. The DCCT Research Group. Effects of age, duration and treatment of insulin-dependent diabetes mellitus on residual β-cell function: observations during eligibility testing for the Diabetes Control and Complications Trial (DCCT). J. Clin. Endocrinol. Metab. 65 (1987) 30-36
14. The Diabetes Control and Complications Trial Research Group. Effect of intensive therapy on residual β-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial. Ann. Intern. Med. 128 (1998) 517-523
15. U.K. Prospective Diabetes Study Group. U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: A progressive disease. Diabetes 44 (1995) 1249-1258
16. Bell G.I., Pilkis S.J., Weber I.T., and Polonsky K.S. Glucokinase mutations, insulin secretion, and diabetes mellitus. Annu. Rev. Physiol. 58 (1996) 171-186
17. Stoffers D.A., Ferrer J., Clarke W.L., and Habener J.F. Early-onset type-II diabetes mellitus (MODY4) linked to IPF1. Nat. Genet. 17 (1997) 138-139
18. +/- mice. J. Clin. Invest. 111 (2003) 1147-1160
19. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
20. Wallace T.M., Levy J.C., and Matthews D.R. Use and abuse of HOMA modeling. Diabetes Care 27 (2004) 1487-1495